MicroRNA-146a polymorphisms are Associated with Psoriasis Vulgaris

Introduction

Psoriasis is one of the most common skin disorders resulting from a complex interplay among the susceptibility genes and autoimmune system¹. Psoriasis vulgaris (PsV), the most common subtype of psoriasis, is characterized by the emergence of hyperkeratosis, parakeratosis and orthokeratosis². However, the molecules pathogenesis of psoriasis is still not completely elucidated.

The microRNAs represent a class of is short and regulatory RNAs that regulate RNA silencing and post-transcriptional process. Recently studies have also shown that the noncoding RNAs (including microRNAs) may be a crucial regulator in human life and so many human diseases³. Furthermore, the majority of protein-coding genes may be regulated by microRNAs. Accordingly, microRNAs have been implicated in almost all biological processes, in particular cell differentiation, development and the signaling pathways³. In recent years, evidence is accumulating for the role of microRNAs in the pathogenesis of psoriasis rapidly ⁴. Specifically, many studies have confirmed that single nucleotide polymorphisms (SNPs) located in microRNAs genes associated with the susceptibility to psoriasis^4,5.

Of the susceptibility microRNAs to psoriasis, MicroRNA-146a is one of the most highly associated MicroRNA to psoriasis ^6-8. Several studies have found that MicroRNA-146a Increased both in the epidermal and dermal compartments of psoriatic skin ^7,9. Chatzikyriakidou et al ¹⁰ have shown the association between psoriatic arthritis risk in a cohort of patients with psoriasis from Greece and specific polymorphisms found in MicroRNA-146a (rs2910164) and one of its targets IRAK1 (rs3027898, rs1059703). In his study, a very strong association with the rs3027898 IRAK1 variant was also observed ¹⁰. Specifically, the rs2910164G allele resulted in reduced levels of MicroRNA-146a and impairment of its ability to regulate endothelial growth factor receptor, an important proliferative signal in keratinocytes and psoriasis skin ¹¹.

On the other hand, previously study have identified that ETS proto-oncogene 1, transcription factor (ETS1) could affects MicroRNA-146a promoter activity markedly in vitro, by binding the MicroRNA-146a promoter region¹². Furthermore, knockdown of ETS1 impaired the induction of miR-146a, whereas overexpression of ETS1 enhanced the induction of MicroRNA-146a in vivo experiments. Actually, ETS1 is involved in various immune responses. ETS1 plays a role in immunity, angiogenesis, and cancer progression, and is expressed in B cells, T cells, natural killer cells, endothelial cells, and cancer cells ^13-15. In T cells, reduction of T helper (Th) 1 cytokine, interferon γ, and decrease in regulatory T cells (Tregs) were observed in Ets1-deficient mice. On the other hand, Th17 differentiation was enhanced by Ets1 deficiency^13-15. It has also been shown that SNP rs1128334 and rs10893872 located in the 3’-untranslated region (3’-UTR) of Ets-1 are on putative miRNA binding sites and are both associated with SLE in Asian populations¹². All these results may suggest that Ets-1 influences the activity of MicroRNA-146a and it may take some role in the immunity pathogenesis of psoriasis.

In this study, we aimed to examined the association of MicroRNA-146a, Ets-1(its negative regulator) and IRAK1(its target) gene polymorphisms with PsV in a Southern Han Chinese cohort.

Materials and methods

Results

Discussion

We conducted the study to evaluate the association between 7 SNPs of MicroRNA-146a gene, Ets-1(its negative regulator) and IRAK1(its target) polymorphisms and risk factors on PsV.

As we know, MicroRNAs are an abundant class of small noncoding RNA molecules, and have been recently recognized as an important regulator in immune homeostasis ³. As MicroRNA-146a is a crucial negative regulator of the immune response by negatively regulating NF-κB dependent inflammatory signals via direct targeting of IL-1 receptoreassociated kinase 1 (IRAK1) ^20,21. NF-κB is a protein transcription factor and a key regulatory element in a variety of immune and inflammatory pathways, in cellular proliferation and differentiation. Furthermore, NF-κB has been hypothesized to connect the altered keratinocyte and immune cell behavior that characterizes the psoriatic milieu ^21,22.

Moreover, recent studies have demonstrated that SNPs located either in the pre-miRNAs or within miRNA binding sites may contribute to the susceptibility to diseases. Within MicroRNA-146a, several SNPs (rs2910164 and rs2431697) which could lead to the alteration of microRNA function or expression have been noted^23,24. Specifically, rs2910164 in the pre-miRNA sequence is thought to result in reduced levels of both the pre and mature miRNA. And previously studied found the association between psoriatic arthritis risk in a cohort of patients with psoriasis from Greece and specific polymorphisms found in microRNA-146a (rs2910164) and one of its known targets, IRAK1 (rs3027898, rs1059703) ¹⁰. In contrast, a separate study showed that the rs2910164 microRNA-146a allele was associated with increased psoriasis susceptibility in Han Chinese patients¹¹. The rs2910164 variant C-allele also play a role in the progression of PsA in the South African Indian population²⁵. Specifically, the rs2910164G allele resulted in reduced levels of microRNA-146a and impairment of its ability to regulate endothelial growth factor receptor, an important proliferative signal in keratinocytes and psoriasis skin¹¹. Srivastava et al report protective association of a functional polymorphism in the MicroRNA-146a precursor (rs2910164). Genetic deficiency in MicroRNA-146a leads to earlier onset and exacerbated pathology of skin inflammation, with increased expression of IL-17–induced keratinocyte-derived inflammatory mediators, epidermal hyperproliferation, and increased neutrophil. infiltration. Moreover, they also shown that MicroRNA-146a –deficient mice do not resolve inflammation after discontinuation of imiquimod challenge. The overexpression of MicroRNA-146a suppressed, whereas its inhibition enhanced, IL-17–driven inflammation in keratinocytes. Functionally, MicroRNA-146a impairs the neutrophil chemoattractant capacity of keratinocytes. Finally, delivery of MicroRNA-146a mimics into the skin leads to amelioration of psoriasiform skin inflammation, decreased epidermal proliferation, and neutrophil infiltration. Their results define a crucial role for MicroRNA-146a in modulating IL-17–driven inflammation in the skin²³.

In addition, strong evidence indicates that rs2910164 leads to increased or decreased microRNA-146a expression in a cell type-dependent manner. For instance, Jazdzewski et al. reported that rs2910164 C allele displayed a 1.8-fold lower level of mature MicroRNA-146a compared to those harboring the G allele²⁶. Likewise, Xu et al. found that the G-allelic MicroRNA-146a precursor yielded more mature MicroRNA-146a compared to the C allelic precursor in the 293T cell line²⁷. On the other hand, Shen et al. found that MicroRNA-146a expression was 60% higher in the C allele than the G allele in the MCF-7 cell, a model system for breast cancer ²⁸. The disparate effects of the rs2910164 C allele on the expression level of MicroRNA-146a may explain the equally disparate effects the SNP has on autoimmune diseases that are localized to different tissues or affect different cell types such as psoriasis and ankylosing spondylitis²⁴.

In our study, we found the allele and genotypes of rs2910164 and rs2431697 of MicroRNA-146a associated with the risk of PsV. The associations of the other SNPs within the susceptibility loci remain unclear and further studies are necessary to achieve better understanding the genetic components of PsV. Despite the fact that the function experiments were not carrying out to further illustrate this phenomenon from the level of genetic epidemiology. The findings could make a significant step forward in our understanding of the genetic contribution to psoriasis.